48 results on '"Manceau, Hana"'
Search Results
2. Association of Sepsis With Neurologic Outcomes of Adult Patients Treated With Venoarterial Extracorporeal Membrane Oxygnenation
3. Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosis
4. Evaluation of iron metabolism in hospitalized COVID-19 patients
5. Marked microcytosis and increased transferrin saturation: Think about variants in SLC11A2 (DMT1)
6. Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease
7. Mutation in human CLPX elevates levels of δ -aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria
8. Quantification of Urine and Plasma Porphyrin Precursors Using LC–MS in Acute Hepatic Porphyrias: Improvement in Routine Diagnosis and in the Monitoring of Kidney Failure Patients
9. Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation
10. Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma
11. Characterization and origin of heme precursors in amniotic fluid: lessons from normal and pathological pregnancies
12. Reversible atransferrinemia in a patient with chronic enteropathy: is transferrin mandatory for iron transport?
13. Anémies microcytaires rares
14. Red cells from ferrochelatase-deficient erythropoietic protoporphyria patients are resistant to growth of malarial parasites
15. Reversible atransferrinemia in a patient with chronic enteropathy
16. Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency
17. Hepatocyte-derived biomarkers concentrations predict liver-related events within 2 years in patients with Child-Pugh class A alcohol-related cirrhosis
18. Fecal calprotectin in inflammatory bowel diseases: update and perspectives
19. Review of: "Loss of Function of mtHsp70 Chaperone Variants Leads to Mitochondrial Dysfunction in Congenital Sideroblastic Anemia"
20. Givosiran in acute intermittent porphyria: A personalized medicine approach
21. Iron deficiency in chronic inflammatory bowel diseases: an update
22. Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1
23. LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders
24. I-FABP is decreased in COVID-19 patients, independently of the prognosis
25. A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria
26. Ferroptosis in Liver Diseases: An Overview
27. TSPO2 translocates 5‐aminolevulinic acid into human erythroleukemia cells
28. Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma
29. GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia
30. Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword
31. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria
32. From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria
33. CHARACTERIZATION OF HEME-INDUCED TOXICITY AND FERROPTOSIS IN PLACENTAL CELLS.
34. Non syndromic childhood onset congenital sideroblastic anemia: A report of 13 patients identified with an ALAS2 or SLC25A38 mutation.
35. Personalized medicine, pharmacogenomic and companion biomarker
36. Acute hepatic and erythropoietic porphyrias: from ALA synthases 1 and 2 to new molecular bases and treatments
37. Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives
38. Erythropoietic Protoporphyric Red Blood Cells Are Resistant to the Growth of Malarial Parasites
39. Médecine personnalisée, strati?ée, pharmacogénomique et biomarqueurs compagnons.
40. Antisense Oligonucleotide-Based Therapy in Human Erythropoietic Protoporphyria
41. Intérêt du dosage de la calprotectine fécale dans les maladies inflammatoires chroniques de l'intestin État des lieux et perspectives.
42. TSPO2 translocates 5-aminolevulinic acid into human erythroleukemia cells
43. Marked microcytosis and increased transferrin saturation: Think about variants in SLC11A2 (DMT1).
44. Fecal let-7b and miR-21 directly modulate the intestinal microbiota, driving chronic inflammation.
45. Reversible atransferrinemia in a patient with chronic enteropathy: is transferrin mandatory for iron transport?
46. Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency.
47. Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria.
48. Rare microcytic anemias.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.